Phase I--II trial design for biologic agents using conditional auto-regressive models for toxicity and efficacy
From MaRDI portal
Publication:6642058
DOI10.1111/rssc.12314MaRDI QIDQ6642058
Thomas M. Braun, Jeremy Michael George Taylor, Daniel G. Muenz
Publication date: 21 November 2024
Published in: Journal of the Royal Statistical Society. Series C. Applied Statistics (Search for Journal in Brave)
randomizationclinical trialimmunotherapydose findingmolecularly targeted agentbiologically optimal dose
This page was built for publication: Phase I--II trial design for biologic agents using conditional auto-regressive models for toxicity and efficacy